Trial Profile

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 15 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 4D 710 (Primary)
Indications Cystic fibrosis
Focus Adverse reactions
Acronyms AEROW
Sponsors 4D Molecular Therapeutics

Most Recent Events

28 Feb 2025 According to a 4DMT media release, enrollment extension of three additional participants in Cohort 4 ongoing. Interim data and program update from trial expected at a scientific conference in H2 2025.
10 Jan 2025 Status changed from recruiting to active, no longer recruiting, as per 4DMT media release.
10 Jan 2025 According to a 4DMT media release, enrollment completed in November 2024 (Cohorts 3 & 4 fully enrolled with n=3 each),Interim data update expected to be presented in mid-2025 at a scientific conference.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com